SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Based in the United States, Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors and will help lead the company's financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.
Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations.
SS Innovations develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
The appointment of Romano is significant as SS Innovations seeks to gain regulatory approval in the United States, a key milestone for the company. With her experience in raising capital and managing financial operations in the medtech space, Romano is expected to play a crucial role in securing the funding needed for clinical trials and regulatory submissions. The company's focus on affordability could disrupt the robotic surgery market, which is currently dominated by high-cost systems. For more details, see the full press release at https://ibn.fm/pAqlP.
SS Innovations International (NASDAQ: SSII) is committed to expanding access to robotic surgery globally. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII.
